The gut microbiota modulates host amino acid and glutathione metabolism in mice by Mardinoglu, Adil et al.
Article
The gut microbiota modulates host amino acid and
glutathione metabolism in mice
Adil Mardinoglu1,2,†,*, Saeed Shoaie1,†, Mattias Bergentall3,4, Pouyan Ghaffari1, Cheng Zhang2,
Erik Larsson3,4, Fredrik Bäckhed3,4 & Jens Nielsen1,2
Abstract
The gut microbiota has been proposed as an environmental factor
that promotes the progression of metabolic diseases. Here, we
investigated how the gut microbiota modulates the global meta-
bolic differences in duodenum, jejunum, ileum, colon, liver, and two
white adipose tissue depots obtained from conventionally raised
(CONV-R) and germ-free (GF) mice using gene expression data and
tissue-specific genome-scale metabolic models (GEMs). We created
a generic mouse metabolic reaction (MMR) GEM, reconstructed 28
tissue-specific GEMs based on proteomics data, and manually
curated GEMs for small intestine, colon, liver, and adipose tissues.
We used these functional models to determine the global metabolic
differences between CONV-R and GF mice. Based on gene expres-
sion data, we found that the gut microbiota affects the host amino
acid (AA) metabolism, which leads to modifications in glutathione
metabolism. To validate our predictions, we measured the level of
AAs and N-acetylated AAs in the hepatic portal vein of CONV-R and
GF mice. Finally, we simulated the metabolic differences between
the small intestine of the CONV-R and GF mice accounting for the
content of the diet and relative gene expression differences. Our
analyses revealed that the gut microbiota influences host amino
acid and glutathione metabolism in mice.
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Introduction
The human gut harbors a vast ensemble of bacteria that have
profound effects on host physiology (Huttenhower et al, 2012).
Complex disorders including obesity (Ley et al, 2006; Turnbaugh
et al, 2009), type 2 diabetes (T2D) (Qin et al, 2012; Karlsson et al,
2013), atherosclerosis (Wang et al, 2011b; Karlsson et al, 2012), and
non-alcoholic fatty liver disease (NAFLD) (Henao-Mejia et al, 2012)
as well as the opposite end of the spectrum, for example, malnu-
trition (Smith et al, 2013; Subramanian et al, 2014), have been
associated with dysbiosis in the human gut microbiota. To gain
mechanistic insights into the contribution of specific microbial popu-
lations to the progression of such disorders, germ-free (GF) animals
(e.g. mice and rats) have been adopted for studying the association of
the gut microbiota with disease pathogenesis (Ridaura et al, 2013).
Comparisons between GF and conventionally raised (CONV-R)
mice are often used for studying the effect of gut microbiota on
host physiology (Wostmann, 1981; Stappenbeck et al, 2002; Claus
et al, 2008; Slack et al, 2009; El Aidy et al, 2013). Moreover,
Larsson et al (2012) studied the response of the host induced by
microbiota along the length of the gut in CONV-R and GF C57Bl6/J
mice and provided a detailed description for tissue-specific host
transcriptional responses.
Global metabolic differences of cells/tissues between different
clinical conditions can be revealed through the use of genome-scale
metabolic models (GEMs) (Mardinoglu & Nielsen, 2012, 2015;
Yizhak et al, 2013, 2014a,b; Bordbar et al, 2014; Shoaie & Nielsen,
2014; O’Brien et al, 2015; Varemo et al, 2015; Zhang et al, 2015).
GEMs include the known metabolism-related reactions and associ-
ated genes in a particular cell and tissue and serve as an excellent
scaffold for the integration of omics data (e.g. proteomics, transcrip-
tomics, and metabolomics) for increasing our understanding of the
relationship between genotype and phenotype (Mardinoglu et al,
2013b). To date, simulation-ready cell-/tissue-specific GEMs (Gille
et al, 2010; Karlstaedt et al, 2012; Mardinoglu et al, 2013a, 2014a)
and automatically reconstructed GEMs (Jerby et al, 2010; Agren
et al, 2012; Wang et al, 2012; Yizhak et al, 2014a; Uhlen et al,
2015) have been used for studying the metabolism of cells/tissues
in health and disease states.
In order to examine the gut microbiota-induced transcriptional
responses of the host metabolism, we performed microarray
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analysis of liver as well as epididymal and subcutaneous white
adipose tissues (WATs) obtained from both CONV-R and GF mice,
and analyzed the global gene expression profile of these tissues
together with the previously published gene expression profiles of
duodenum, jejunum, ileum, and colon tissues. We created a
generic mouse metabolic reaction (MMR) GEM and generated
tissue-specific mouse GEMs primarily based on proteomics data.
We investigated the metabolic differences between CONV-R and
GF mice using global gene expression profiling of the host tissues
and the network topology provided by the tissue GEMs, and
validated our predictions by generating metabolomics data for
these two sets of mice. Finally, we revealed the metabolic dif-
ferences between the small intestine of CONV-R and GF mice
accounting for the content of the chow diet as well as the relative
gene expression differences using relative metabolic differences
(RMetD) method.
Results
Global transcriptional profiles of CONV-R and GF mice
CONV-R and GF C57Bl6/J male mice were fed autoclaved chow diet
ad libitum and then euthanized at 12–14 weeks of age (Larsson
et al, 2012). We isolated RNA from liver as well as epididymal and
subcutaneous WATs obtained from CONV-R and GF mice and
performed global transcriptome analysis (Fig 1A). Small intestine
and colon have been previously removed from the same two sets of
mice, and small intestine has been divided into eight whereas the
colon into three equal-sized segments (Larsson et al, 2012). Global
transcriptome analysis was performed for the first (duodenum), fifth
(jejunum), and eighth (ileum) segments of the small intestine and
the proximal piece of the colon (Fig 1A).
We performed principal component analysis (PCA) of the tran-
scription profiles for the tissues separately and observed a clear
separation between the CONV-R and GF mice for duodenum,
jejunum, ileum, colon, and liver, whereas no separation was
found for both WATs (Fig EV1). We identified significantly dif-
ferentially expressed probe sets and genes in MMR, from here on
referred as metabolic genes, by comparing gene expression
profiles of tissues obtained from CONV-R versus GF mice (Fig 1B,
Dataset EV1). During the identification of the significantly
(Q-value < 0.05) differentially expressed probe sets and metabolic
genes, we adjusted P-values using the false discovery rate (FDR)
method and calculated Q-values. We found that ileum tissue had
the largest number of differentially expressed metabolic genes
between CONV-R and GF mice, and it was followed by duode-
num, jejunum, colon, and liver tissues (Fig 1B). It should also be
noted that we only detected two significantly differentially
expressed metabolic genes between the subcutaneous WAT
whereas no differentially expressed metabolic genes between the
epididymal WAT.
Comparing the differentially expressed metabolic genes between
duodenum, jejunum, ileum, colon, and liver tissues of CONV-R
and GF mice (Fig 1C), we found that the expression of the nicotin-
amide nucleotide transhydrogenase (Nnt) gene is higher and
ectonucleoside triphosphate diphosphohydrolase 4 (Entpd4) is
lower in all five tissues of CONV-R mice compared with GF mice
(Fig 1D). Strikingly, we found that Nnt and Entpd4 are also the
only differentially expressed genes in the subcutaneous WAT of
the CONV-R mice compared with GF mice and followed the same
directional changes in the subcutaneous WAT as in all other five
analyzed tissues. Entpd4 was initially named human Golgi
UDPase, and it hydrolyzes nucleoside diphosphates. UDP is the
best substrate for this enzyme, and its ADP activity is insignificant.
Nnt is required for regular mitochondrial function, and it uses
energy from the mitochondrial proton gradient to transfer reducing
equivalents from NADH to NADPH. The resulting NADPH is used
for driving macromolecular biosynthesis as well as for the reduc-
tion of glutathione (GSH) (Fig 1D). Here, we focused on the meta-
bolic differences associated with Nnt due to its well-known
metabolic function.
Creation of MMR and reconstruction of mouse
tissue-specific GEMs
We constructed MMR by using the mouse orthologs of human
genes in HMR2 (Mardinoglu et al, 2014a) (Fig 2A), and the result-
ing generic model includes 8,140 metabolism-related reactions,
3,579 associated metabolic genes to those reactions, and 5,992
metabolites in eight different subcellular compartments. Previously,
stable isotope labeling with amino acids (SILAC)-based proteomics
was generated to analyze the expression of 7,349 proteins in 28 dif-
ferent major C57BL/6 mouse tissues (Geiger et al, 2013) and these
data cover 2,030 of the protein-coding genes in MMR (Fig 2B,
Dataset EV2). We reconstructed tissue-specific GEMs for 28 mouse
tissues by using proteomics data, MMR, and the tINIT algorithm
(Agren et al, 2014) (see Materials and Methods). The tINIT algo-
rithm allows for the reconstruction of functional GEMs based on
global proteomics data as well as user-defined metabolic tasks,
which the resulting model should be able to perform. During the
reconstruction of the models, we complemented 56 metabolic tasks
(functions) (Agren et al, 2014), which are known to occur in all
cells/tissues.
The number of reactions, metabolites, and genes incorporated in
the models are presented in Dataset EV3. A total of 5,813 reactions,
4,574 metabolites, and 1,838 genes were shared across the tissue-
specific GEMs of which 2,750 (47.3%) reactions, 3,001 (65.6%)
metabolites, and 669 (36.4%) genes were common to all tissue-
specific GEMs. We found that 322 reactions, 134 metabolites, and
120 genes were incorporated into only one specific GEM (Fig 2C).
By pairwise comparison of GEMs, we found that each model has an
average of 765 reactions (Dataset EV4), 430 metabolites (Dataset
EV5), and 342 genes (Dataset EV6) different from other tissues
where the muscle tissue was the one with the highest average
difference (Fig 2C).
We analyzed the heterogeneity of the mouse tissue-specific GEMs
(Fig 2D) in terms of incorporated reactions, genes, and metabolites
by calculating the heterogeneity degree of each model. The hetero-
geneity degree allowed us to capture the divergence between meta-
bolic networks based on their constituent parameters including
reactions, metabolites, and genes, and it was calculated using the
average and maximum Hamming distance of the models (Ghaffari
et al, 2015). Moreover, we analyzed the heterogeneity of recently
reconstructed human cell-specific GEMs (Agren et al, 2014) that
have been reconstructed based on antibody-based proteomics data
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in the Human Protein Atlas (www.proteinatlas.org) (Uhlen
et al, 2010, 2015; Kampf et al, 2014b). On average, mouse tissue-
specific GEMs showed an average heterogeneity degree of 0.77 for
reactions, 0.72 for metabolites, and 0.78 for genes, whereas human
cell-specific GEMs had an average heterogeneity degree of 0.8 for
reactions, 0.7 for metabolites, and 0.84 for genes (Fig 2D).
Compared with the human cell-specific GEMs, the mouse tissue-
specific GEMs had a slightly higher metabolic uniformity and lower
heterogeneity based on the incorporated genes and reactions, but
they had a slightly higher heterogeneity based on the incorporated
metabolites into the models.
We next incorporated the significantly differentially expressed
genes between CONV-R and GF mouse tissues and generated four
functional GEMs for liver (iMouseLiver), adipose (iMouseAdipose),
colon (iMouseColon), and small intestine (iMouseSmallintestine),
with the latter reconstructed by merging the GEMs for duodenum,
jejunum, and ileum tissues. During manual evaluation of the GEMs,
previously published functional human cell-type GEMs for hepato-
cytes in liver tissue (Mardinoglu et al, 2014a) and adipocytes in
adipose tissue (Mardinoglu et al, 2013a, 2014b) were also used to
include known biological functions to the GEMs. The number of the
incorporated reactions, metabolites, and genes in the four functional
annotated tissue-specific GEMs as well as in the draft GEMs is
provided in Dataset EV3. MMR as well as the all mouse tissue-
specific models are publicly available in systems biology markup
language (SBML) format at the Human Metabolic Atlas portal
(www.metabolicatlas.org) (Pornputtapong et al, 2015), at the
BioModels database and as Computer Code EV1.
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Figure 1. Global gene expression profiling of tissues obtained from CONV-R and GF mice.
A Liver as well as epididymal and subcutaneous WATs was obtained from both CONV-R and GF mice, and global gene expression profiling was generated using
microarrays. Transcriptomics data for these three tissues were analyzed together with the previously published gene expression profiling of duodenum, jejunum,
ileum, and colon tissues.
B Gene expression data for each tissue were normalized independently of other tissues, and significantly (Q-value < 0.05) differentially expressed probe sets and
metabolic genes in Mouse Metabolic Reaction database were presented in each analyzed tissue.
C The overlap between the significantly (Q-value < 0.05) and differentially expressed metabolic genes in duodenum, jejunum, ileum, colon, and liver is presented.
D The significantly (Q-value < 0.05) and differentially expressed metabolic genes, Nnt, and Entpd4, as well as the reactions associated with Nnt, are presented. Red and
blue arrows indicate the significantly higher (Q-value < 0.05) and lower expression of the metabolic genes in CONV-R mice compared to GF mice, respectively.
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Figure 2. Creation of MMR and generation of tissue-specific GEMs.
A Mouse Metabolic Reaction database (MMR) was created using the mouse orthologs of human genes based on Human Metabolic Reaction database 2.0 (HMR2).
B The expression level of the 2,032 proteins used in the generation of the 28 tissue-specific mice models is presented.
C Bar plots represent the distribution of tissue-specific reactions, metabolites, genes, and metabolites across the 28 mouse tissue GEMs. Filled circles depict average
distance of each tissue GEMs compared to others. Average distance, calculated based on Hamming distance method, indicates required alteration to transform one
tissue model to the other based on the reactions and metabolites and genes. For instance, 478 changes in gene profile are required for intertransformation of GEM
for lung and stomach, from which 401 changes in genes correspond to transformation of lung to stomach and 77 changes in genes correspond to transformation of
stomach to lung.
D Filled circles represent the heterogeneity degree of 28 mouse tissues and 83 healthy human cell types. Heterogeneity values are projected on the left hand side axis.
There is a fall, ~0.06 degree, in heterogeneity of mice models compared to human modes based on genes and a lower decrease, ~0.03, based on the reactions.
However, comparing mouse tissues to human cells revealed higher heterogeneity based on the metabolites, in contrast to the reaction and genes. Average Hamming
distance of GEMs for mouse tissues and human cell types are projected on the right hand axis. Mouse tissues have relatively less, 40–60%, inter-model distance
compared to human cells based on the reactions and genes. However, the trend is reversed with around 50% increased inter-model distance for metabolites. In
general, mouse tissue-specific GEMs show gain of heterogeneity based on metabolites and loss of heterogeneity based on genes.
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Decreased glutathione synthesis in the small intestine of
CONV-R mice
We compared the gene expression profiling in the small intestine
segments (duodenum, jejunum and ileum) of CONV-R and GF mice,
and examined the changes in the expression of the genes interacting
with Nnt using the network structure provided by iMouse-
Smallintestine (Fig 1D). We found that the expression of glutathione
reductase (Gsr) which uses NADPH as an electron donor to reduce
glutathione disulfide (GSSG) to GSH was also significantly higher
(Q-value < 0.05) in all three small intestine segments of CONV-R
mice compared to GF mice (Fig 3A, Dataset EV1). GSH plays a
key role in reducing oxidative stress, and it can be synthesized
within the cells from glutamate, cysteine, and glycine through
the use of glutamate-cysteine ligase catalytic subunit (Gclc),
glutamate-cysteine ligase modifier subunit (Gclm), and glutathione
synthetase (Gss). We found that the expression of Gclc is signifi-
cantly lower (Q-value < 0.05) in jejunum and ileum, and the expres-
sions of Gclm and Gss are significantly lower (Q-value < 0.05) in
the ileum of CONV-R mice compared to GF mice (Fig 3A). Based on
gene expression data, we observed that decreased de novo synthesis
of GSH in the small intestine of CONV-R mice was compensated by
higher expression of Nnt and Gsr compared to GF mice.
The decreased synthesis of the GSH in the small intestine
segments of CONV-R mice may be due to the limited availability of
the substrates including glutamate, cysteine, and glycine. Hence, we
examined the expression of the enzymes involved in the synthesis
and catabolism of these amino acids by differentially expressed
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Figure 3. Metabolic differences in the small intestine.
A Metabolic genes as well as the associated reactions involved in the formation of glutathione (GSH) are presented.
B, C Significant differences associated with (B) glycine and (C) glutamine are shown. Red and blue arrows indicate the significantly (Q-value < 0.05) higher and lower
expression of the metabolic genes in CONV-R mice compared to GF mice, respectively.
D The levels of glycine, glutamine, and cysteine used in the de novo synthesis of the GSH are measured in the hepatic portal vein that conducts blood from the
gastrointestinal tract to the liver tissue. *Q-value < 0.05.
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genes in the small intestine (Dataset EV7) and using the
network topology provided by iMouseSmallintestine. We integrated
differentially expressed genes in duodenum, jejunum, and ileum
using the lowest Q-value for the genes and associated fold changes
for studying the metabolic differences between the small intestine of
CONV-R and GF mice (Dataset EV7). Hereby, we identified signifi-
cantly (Q-value < 0.05) differentially expressed genes linked to
biosynthesis of glycine (Fig 3B) and glutamate (Fig 3C) and found
that there are metabolic differences in the utilization of these AAs
between CONV-R and GF mice. In contrast, we did not detect any
significant change in the expression of the genes linked to cysteine
except Gclc and Gclm (Dataset EV7).
In healthy animals, AAs in the small intestine are released in the
plasma and utilized by other peripheral tissues (e.g. liver, adipose,
and muscle tissues). Considering the down-regulation of genes asso-
ciated with de novo synthesis of GSH and of glutamate and glycine
required for GSH biosynthesis in the small intestine in CONV-R
mice, we hypothesized that the plasma level of glutamate and
glycine secreted from the small intestine in CONV-R mice may also
be lower compared with GF mice. Hence, we measured the level of
these two AAs in the hepatic portal vein (PV), which conducts blood
from the gastrointestinal tract to the liver, of CONV-R and GF mice,
and found that the PV level of glycine was significantly lower
(ANOVA test, Q-value < 0.05) and glutamate is slightly lower in
CONV-R mice compared to GF mice (Fig 3D, Dataset EV8). We also
measured the level of cysteine, likewise used for biosynthesis of
GSH, in the PV of CONV-R and GF mice (Fig 3D) but found no dif-
ferences, in agreement with the fact that there were no significant
changes in the expression of genes encoding enzymes required for
cysteine utilization (Dataset EV7).
We also searched for global metabolic differences in the small
intestine by mapping the gene expression data (Dataset EV7) to the
network topology provided by the small intestine GEM using the
reporter subnetworks algorithm (Patil & Nielsen, 2005). Hereby, we
found that there are major metabolic differences around 17 other
AAs (Dataset EV9). We thus next measured the level of these 17
AAs in the PV and found that the levels of arginine, asparagine,
histidine, isoleucine, leucine, methionine, phenylalanine, proline,
serine, threonine, tryptophan, tyrosine, and valine were signifi-
cantly lower and the level of glutamine was significantly higher in
CONV-R mice compared to GF mice. We did not detect any signifi-
cant changes in the level of alanine, aspartate, and lysine (Fig 4A,
Dataset EV8). Our results indicate that the gut microbiota alter AA
metabolism of the host.
Metabolic differences between the liver tissues of CONV-R and
GF mice
We found that the expression of Nnt was significantly higher and
Entpd4 was significantly lower in the liver tissue of CONV-R
compared to GF mice (Fig 5A) and validated the expression of these
genes by quantitative reverse transcription PCR (RT–PCR) methods
(Fig 5B). We found that glutathione S-transferase pi 1 (Gstp1),
which has a role in GSH metabolism, metabolism of xenobiotics by
cytochrome P450, and drug metabolism, is significantly higher in
CONV-R mice compared to GF mice. Notably, Claus et al (2008)
measured the liver tissue level of GSSG, which is used as a substrate
for the reaction catalyzed by the Gsr in CONV-R and GF mice by
employing a high-resolution 1H NMR spectroscopic approach, and
reported that the liver tissue level of GSSG was significantly higher
in CONV-R mice. Hence, we hypothesized that higher Nnt expres-
sion in CONV-R mice might be the response of liver to the lower
level of glycine required for the de novo synthesis of the GSH. Strik-
ingly, Claus et al (2008) has also measured the glycine level in the
liver tissue of CONV-R and GF mice, and found that the level of
glycine is lower in CONV-R mice compared to GF mice. We also
measured the PV level of serine, which can be taken up by the liver
and converted to glycine, and found that the level of serine was also
significantly lower in CONV-R mice compared to GF mice (Fig 4A).
However, N-acetylated AAs can also be taken up by the liver and
hydrolyzed to acetate and a free AA by aminoacylases, ACY1, ACY2
(ASPA), and ACY3 (Fig 4B) which are predicted to be present in
human liver tissue based on the transcriptomics and proteomics
data (Kampf et al, 2014a; Uhlen et al, 2015). Accordingly, we
measured the level of the acetyl-AAs in the PV and found that the
levels of N-acetyllysine, N-acetylalanine, N-acetylarginine, N-acetyl-
cysteine, N-acetylglutamate, N-acetylglycine, N-acetylisoleucine,
N-acetylleucine, N-acetylmethionine, N-acetylphenylalanine,
N-acetylthreonine, N-acetyltryptophan, N-acetyltyrosine, and N-acetyl-
valine are significantly lower (Q-value < 0.05), whereas N-acetylser-
ine and N-acetylthreonine are slightly (0.05 < Q-value < 0.1) lower
in CONV-R mice compared to GF mice (Fig 4C, Dataset EV8). We
could not detect any significant changes in the level of N-acetyl-
asparagine, N-acetylaspartate, N-acetylglutamine, and N-acetyl-
histidine.
Moreover, we investigated the differences in the expression of
liver tissue genes between CONV-R and GF mice. We found that the
expression of Alas1 involved in glycine metabolism, Slc2a1 known
as Glut1 and involved in glucose transportation, Slc16a12 involved
in creatine transportation, and Hmgcr involved in cholesterol
synthesis as well as Cyp7a1 and Akr1d1 involved in bile acid
synthesis were significantly lower in the liver tissue of CONV-R
mice compared to GF mice (Fig 5A). On the other hand, the expres-
sions of Sdr9c7 involved in vitamin A metabolism, Elovl3 involved
in long-chain fatty acids (FAs) elongation cycle, and Uap1l1
involved in amino sugar and nucleotide sugar metabolism were
significantly upregulated in liver tissue of CONV-R mice compared
to GF mice.
Metabolic differences between the colon tissues
We found that the expression of Sardh that converts sarcosine to the
glycine in the mitochondria is significantly lower (Q-value < 0.05),
whereas the expression of the genes involved in GSH metabolism
including, Gsta4, Gstk1, Gstp1, and Gstt1 is significantly higher
(Q-value < 0.05) in the colon tissue of CONV-R mice compared to
GF mice (Fig 6). Even though degradation of betaine is lower, the
increased expression of glutathione transferases (Gsts) may be
explained by the increased expression of the Nnt in the colon tissue
of CONV-R mice similar to the liver and small intestine tissues of
CONV-R mice.
We also revealed the global metabolic differences (Dataset EV1)
between the colon tissue of CONV-R and GF mice by mapping the
significantly differentially expressed genes to iMouseColon (Fig 6).
We found that the expression of Arg2 involved in arginine metabo-
lism as well as Ces1g, Aldh1a2, and Rbp4 involved in vitamin A
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metabolism was higher in the colon tissue of CONV-R mice
compared to GF mice. On the other hand, we found that Aldob and
Aldh9a1 involved in glycolysis; Hmgcs1, Hsd17b7, Nsdhl, and
Sc4 mol involved in cholesterol synthesis; Mgam and Sis involved
in starch and sucrose metabolism; and Slc2a5, Slc2a9, Sord, and
Khk involved in fructose metabolism as well as Ace2 transcription
factor involved in the conversion of angiotensin were significantly
lower in CONV-R mice (Fig 6). Moreover, we found that the expres-
sion of genes involved in the transport of AAs is significantly lower
in the colon tissue of CONV-R compared with GF mice (Dataset
EV1). Our analysis indicated that the overall central metabolism of
the colon tissue may have reduced activity in CONV-R mice
compared to GF mice based on the gene expression data.
The interactions between the microbiota in the small intestine
When CONV-R and GF C57Bl6/J mice were fed with a standard
autoclaved chow diet, we found that CONV-R mice were eating
approximately 20% more than the GF mice. However, the PV level
of 14 AAs and 13 N-acetylated AAs was significantly lower in
CONV-R mice compared to GF mice (Fig 4A and C), and this may
be due to the consumption of these AAs by the bacteria in the small
intestine.
Bacteroidetes and Clostridium cluster XIVa are among the domi-
nant phyla in the ileum (Zoetendal et al, 2012; Van den Abbeele
et al, 2013). To understand the metabolic interactions between the
gut microbiota as well as their interactions with the small intestine
A
CB
Figure 4. The level of the AAs and N-acetylated AAs in the hepatic portal vein.
A The level of the significantly (Q-value < 0.05) changed amino acids (AAs) including arginine, asparagine, glutamine, histidine, isoleucine, leucine, methionine,
phenylalanine, proline, serine, threonine, tryptophan, tyrosine, valine, and glutamine as well as the non-significantly changed AAs including alanine, aspartate, and
lysine are measured in the hepatic portal vein of CONV-R and GF mice.
B Reactions involved in the hydrolysis of N-acetylated AAs to acetate and a free AA as well as their catalyzing enzymes, aminoacylases, ACY1, ACY2 (ASPA), and ACY3 are
presented.
C The level of the N-acetylated AAs in hepatic portal vein of CONV-R and GF mice are shown in the volcano plot.
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in CONV-R mice, we simulated the interplay between the two key
species Bacteroides thetaiotamicron and Eubacterium rectale as rele-
vant representatives of these two main phyla in the human ileum.
The Community and Systems-level Interactive Optimization toolbox
(CASINO) has recently been developed for studying the interactions
between the gut microbiota and comprises an optimization algo-
rithm integrated with diet analysis to predict phenotypes (Shoaie
et al, 2015). Here, we employed manually reconstructed GEMs for
B. thetaiotamicron and E. rectale (Shoaie et al, 2013) to study the
interactions between the gut microbiota by using CASINO. During
the simulations, we used the content of the autoclaved chow diet
(Dataset EV10) and assumed that maximum 40% of the total protein
may be consumed by the bacteria (set as upper bound), 5% of the
total protein is transferred to the colon tissue, and the remaining
proteins are consumed by the small intestine (Fig 7A) based on a
previous study where the total AAs in the gastrointestinal tract of
CONV-R and GF mice were measured (Whitt & Demoss, 1975). We
also assumed that 40% of the digestible and 5% of the non-
digestible carbohydrates in the diet were consumed by the bacteria
in the small intestine and 5% of the digestible carbohydrates was
transferred to the colon tissue (Gibson & Roberfroid, 1995).
We maximized for the growth of bacteria and predicted the
amount of the short-chain fatty acids (SCFAs) (acetate, propionate
and butyrate) produced by the B. thetaiotamicron and E. rectale
(Fig 7B and Dataset EV11) by setting the content of the diet as upper
bound to the GEMs for bacteria (Dataset EV10). We observed that
part of the acetate produced by the B. thetaiotamicron is consumed
by the E. rectale and contributes to the production of butyrate in
E. rectale. We found that isoleucine, proline, and valine are only
consumed by the E. rectale, and glycine, serine, alanine, cystine,
glutamate, histidine, leucine, lysine, methionine, phenylalanine,
threonine, and tyrosine are consumed by both B. thetaiotamicron
and E. rectale, whereas arginine, aspartate, and tryptophan are not
consumed by neither of these bacteria (Fig 7C and Dataset EV11). It
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Figure 5. Metabolic differences in the liver tissue.
A The significantly (Q-value < 0.05) and differentially expressed metabolic genes in liver tissue of CONV-R mice compared to GF mice are mapped to the functional
GEM for mice liver tissue. Red and blue arrows indicate the significantly (Q-value < 0.05) higher and lower expression of the metabolic genes in CONV-R mice
compared to GF mice, respectively. Thick arrows indicate the liver tissue level of the metabolites.
B The liver tissue expression of Nnt and Entpd4 was measured by RT–PCR.
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should also be noted that the gut microbiota consumed all of the
available glycine, serine, and threonine during the formation of its
biomass.
Metabolic differences between the small intestine of CONV-R
and GF mice
We simulated the metabolic differences between the small intestine
of CONV-R and GF mice accounting for the relative differences in
the global gene expression data of the small intestine using RMetD
method (see Materials and Methods). RMetD is developed to
integrate the up- and down-regulation of the enzymes together with
the calculated corresponding P-values into the GEMs rather than the
absolute values for the expression of the enzymes.
Considering the content of the diet (Dataset EV10) as well as the
calculated bounds for the intracellular reactions in CONV-R and GF
mice using RMetD (Dataset EV12), we optimized for the production
of chylomicrons and compared the amount of chylomicrons and
HDL produced by CONV-R and GF mice (see Materials and Meth-
ods). We predicted that lower levels of chylomicrons and HDL are
secreted by CONV-R mice compared to GF mice (Fig 7D).
We also revealed the changes in metabolic fluxes in the small
intestine of CONV-R and GF in response to gut microbiota, and
which of these differences are likely to be associated with transcrip-
tional changes. Through the use iMouseSmallintestine, we defined a
region of feasible flux distributions using uptake rates for glucose,
SCFAs, AAs, and secretion rates for chylomicrons and HDL in
CONV-R and GF mice that are predicted by the RMetD. We calcu-
lated a set of flux distributions using a random sampling algorithm
(Bordel et al, 2010) which allowed for identification of transcription-
ally regulated reactions. Finally, we calculated the average and stan-
dard deviations for each of the fluxes carried by the reactions, and
compared the changes in fluxes with the changes in the expression
of the genes associated with those reactions. We found that reactions
involved in fatty acid biosynthesis and oxidations are transcription-
ally down-regulated in CONV-R compared to GF mice (Fig 7E).
Discussion
The interactions between the gut microbiota, host tissues of the
gastrointestinal tract, and diet are known to be highly relevant for
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Figure 6. Metabolic differences in the colon tissue.
The significantly (Q-value < 0.05) differentially expressed metabolic genes in colon tissue of CONV-R mice compared to GF mice are mapped to the functional GEM for mice
colon tissue. Red and blue arrows indicate the significantly (Q-value < 0.05) higher and lower expression of the metabolic genes in CONV-R mice compared to GF mice,
respectively.
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the health of the host. In order to understand the effect of the gut
microbiota on host metabolism, we revealed the metabolic dif-
ferences between the continuous gastrointestinal tracts as well as
liver and WATs of CONV-R and GF mice using tissue-specific GEMs.
We observed that the ileum was the tissue that was most affected
by the gut microbiota, followed by the duodenum, jejunum, colon,
liver, and adipose tissues. Even though, gene expression data for
each tissue were analyzed independently, we found that the expres-
sion of the Nnt was significantly higher in CONV-R mice compared
to GF mice and followed the same directional changes in six of the
analyzed tissues.
We validated our GEM-based predictions based on gene expres-
sion data by generating metabolomics data, and comparing the level
of the metabolites in the PV of the CONV-R and GF mice. Taken
together, we found that the levels of the glycine and serine as well
as the N-acetylated form of these two AAs that may be taken up by
the liver tissue and used in GSH synthesis were significantly lower
in the PV of the CONV-R mice compared to GF mice. Considering
the lower expression of the genes involved in glucose uptake as well
as the lower level of glycine in the liver, de novo synthesis of serine
may also be lower in CONV-R mice compared to GF mice. Hence,
we observed that the expression of Nnt is increased in the liver of
CONV-R mice potentially due to the limited availability of glycine
used as a substrate in GSH de novo synthesis.
The expression of Nnt is linked to insulin sensitivity, and higher
plasma insulin concentrations have been reported in CONV-R mice
compared to GF mice (Rabot et al, 2010). Naturally occurring dele-
tion of the Nnt in the C57BL/6J mouse strain has been associated
with impaired glucose homeostasis control and reduced insulin
secretion that is independent of obesity (Freeman et al, 2006).
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Figure 7. In silico simulation of the small intestine.
A The differences in the utilization of proteins, carbohydrates, non-digestible carbohydrates, and fats between the CONV-R and GF mice are presented.
B The production of the short-chain fatty acids including acetate, butyrate, and propionate produced by the gut microbiota in CONV-R mice is shown.
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E Transcriptionally down-regulated (blue arrows) reactions involved in fatty acid biosynthesis and oxidation in small intestine of CONV-R and GF mice are identified
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Suppression of Nnt in PC12 rat pheochromocytoma cells led to
increased oxidative stress with subsequent impairment of mitochon-
drial function (Yin et al, 2012). Moreover, Ripoll et al (2012) over-
expressed the NNT in a macrophage cell line and detected
decreased levels of reactive oxygen species, indicating that NNT
plays a key role in the modulation of the immune response and host
defense against pathogens.
The microbiota-induced transcriptional responses in specific frac-
tions of intestinal epithelial cells have also been recently examined
by a microarray analysis in CONV-R and GF mice (Sommer et al,
2015). It was reported that approximately 10% of the host’s tran-
scriptome, mainly genes involved in immune responses, cell prolif-
eration, and metabolism, was regulated by the microbiota.
The differences between the level of free AAs along the GI tract of
CONV-R and GF mice have been previously reported (Whitt &
Demoss, 1975), and our analysis provided a detailed explanation of
how bacteria may regulate the host AA homeostasis. We provided
an explanation for the higher expression of the Nnt in CONV-R mice,
and observed that the expression of Nnt is increased in CONV-R mice
as a response to the decreased level of de novo GSH synthesis due to
limited availability of glycine. We also found that microbiota in the
small intestine may consume glycine as well as other AAs to support
its growth and survival which leads to the decreased PV levels of the
AAs and regulates the AA and GSH metabolism of the host.
Moreover, we observed that the liver and colon tissues of
CONV-R mice also responded to the lower level of glycine by higher
expression of Nnt, and this indicated that the gut microbiota
regulates AA metabolism not only in the small intestine but also in
the liver and the colon. We investigated the global metabolic
differences between the liver tissue of the CONV-R and GF mice,
and found that the expression of genes involved glucose uptake,
and cholesterol and bile acid biosynthesis were significantly lower
in CONV-R mice. Previously, it has been shown that the activity and
expression of the Cyp7a1, which is the rate-limiting enzyme in bile
acid synthesis, is decreased in the liver of CONV-R mice compared
to GF mice and that the gut microbiota suppress bile acid synthesis
(Sayin et al, 2013). Similarly, lower expression of Hmgcr, which is
involved in the cholesterol synthesis, has been reported in CONV-R
mice compared to GF mice (Sayin et al, 2013).
Our analysis also indicated that the gut microbiota regulates the
host lipid metabolism. We simulated the metabolic differences
between the small intestine of CONV-R and GF mice by integrating
relative small intestine gene expression data. We found that lower
level of chylomicrons and HDL is produced by the small intestine of
the CONV-R. Our RMetD predictions were in agreement with experi-
mental studies in which 40% lower chylomicron levels in CONV-R
mice compared to GF mice was detected (Velagapudi et al, 2010)
and contribution of gut microbiota on the intake of fats was investi-
gated in CONV-R and GF mice (Duca et al, 2012).
There are several advantages of RMetD compared to previously
developed methods for integrating transcriptomics data into
constraint-based models of metabolism (Machado & Herrgard,
2014). Firstly, it only considers enzyme up-/down-regulation rather
than their absolute expression. This is based on the assumption that
up-/down-regulation of a specific enzyme likely suggests a higher/
lower flux in its corresponding reaction. This could be a better solu-
tion than inferring fluxes by comparing absolute expression level of
different enzymes. In addition, RMetD pushes the flux ranges
instead of the absolute fluxes. Pushing the ranges is more reason-
able since in our case (and in most cases), the reference flux distri-
bution of a GEM is unlikely to be exact, but the ranges are much
more reliable. Furthermore, multiple objective products could be
included in RMetD, and this could be of special interest for those
using mammalian tissue GEMs since they usually have more than
one obligatory functions and products.
Even though RMetD and other methods (Machado & Herrgard,
2014) for inferring flux rates from gene expression data have been
developed, the correlation between the fluxes carried by the reaction
and the expression of the gene catalyzing the reaction is known to
be limited (Bordel et al, 2010). Changes in gene expression levels
therefore only serve only as cues for the likelihood that there may
be an altered metabolic flux carried by the associated reaction. To
validate gene expression data-based predictions, we performed
metabolomics analysis in the PV of the both CONV-R and GF mice
and these data supported functional changes in the pathways show-
ing altered gene expression.
The functional output and diversity of the gut microbiota are
important modulators for the development of various human disor-
ders. Alterations in gut microbiota composition and function have
been shown in the pathogenesis of obesity (Ley et al, 2006;
Turnbaugh et al, 2009), T2D (Qin et al, 2012; Karlsson et al, 2013)
and NAFLD (Henao-Mejia et al, 2012). Imbalances in the plasma
level of glycine as well as other AAs have also been shown in
obesity (Newgard et al, 2009), T2D (Wang et al, 2011a), and
NAFLD (Kalhan et al, 2011). Strikingly, the plasma levels of glycine
are decreased in all subjects with the above-mentioned diseases
compared to the healthy subjects. Moreover, we have recently
found that the expression of the NNT is significantly increased in
both subcutaneous and visceral AT after extensive weight loss in
response to bariatric surgery (Mardinoglu et al, 2015). In this
context, it is of interest to study the microbial AAs in the human GI
tract in relation to its potential role in the development of such
metabolism-related disorders.
In conclusion, we observed that gut microbiota has a profound
systemic effect on AA and GSH as well as lipid metabolism, and it is
one of the major regulators of metabolism in mammals. We demon-
strate that a detailed understanding of the metabolic differences
between CONV-R and GF mice obtained through GEM modeling
may allow for revealing the key roles of the gut microbiota. Our
findings may be used for investigating the contribution of the gut
microbiome in the progression of metabolism-related disorders as
well as for elucidating the unknown etiology of such disorders.
Materials and Methods
Mice
Male C57Bl6/J mice aged 12–14 weeks were used in these experi-
ments. CONV-R mice were housed in individually ventilated cages,
and GF mice were housed in flexible film isolators, with maximum 5
mice per cage, and fed a normal chow ad libitum. GF status was
verified regularly by anaerobic culturing in addition to PCR for
bacterial 16S rDNA. Light cycle was 12/12 h dark/light and lights on
at 06:00. Mice were euthanized by cervical dislocation, and tissues
were collected in liquid nitrogen immediately. All procedures were
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approved by the Gothenburg University Ethical Committee (Permit No.
339/2012).
RNA from the liver as well as epididymal and subcutaneous
WATs obtained from CONV-R and GF mice were isolated using the
RNeasy Lipid Tissue Mini Kit (Qiagen, Hilden, Germany). RNA
concentration and quality were evaluated by spectrophotometric
analysis (ND-1000; NanoDrop Technologies, Wilmington, DE, USA)
and capillary electrophoresis on a 2100 Bioanalyzer (Agilent Tech-
nologies, Santa Clara, CA, USA). Tissue samples with no quality
issues were used in the generation of the gene expression data.
Transcriptomics data
Global gene expression profiling of liver as well as epididymal and
subcutaneous WATs was measured using MoGene 1.0 ST chips
(Affymetrix). CEL files for duodenum, jejunum, ileum, and colon
tissue of CONV-R and GF mice were retrieved from Gene Expression
Omnibus (GEO) public repository under the accession number
GSE17438.
Raw data for each tissue were preprocessed independent of the
other tissues and normalized with robust multi-array average
(RMA) using Piano R package (Va¨remo et al, 2013). Probes which
are not mapped to any gene from the analysis were removed, and
the differential expression analysis for 23,736 probe sets between
CONV-R and GF mice was carried out by calculating two-way analy-
sis of variance (ANOVA) P-values. P-values were adjusted for multi-
ple testing using the R-function p.adjust with the method set to false
discovery rate (FDR), and Q-values were calculated. Q-values were
used for network-dependent analysis.
During the simulation of the metabolic differences between the
small intestine of CONV-R and GF mice, gene expression data for
duodenum, jejunum, and ileum were integrated. However, acyl-CoA
dehydrogenase, long chain (Acadl), cell division cycle 14A
(Cdc14a), cystic fibrosis transmembrane conductance regulator
(Cftr), cathepsin B (Ctsb), fructose-1,6-bisphosphatase 1 (Fbp1),
and 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 (Pfkfb3),
which were significantly changed (Q-value < 0.05) in different
directions between the segments of the small intestine, were not
included into our analysis.
Raw data for liver as well as epididymal and subcutaneous WATs
will be deposited in GEO public repository under the accession
number GSE31115. To make the gene expression data easily avail-
able to the scientific community, the data are also included into the
searchable database (http://microbiota.wall.gu.se).
RT–PCR
Liver tissue samples obtained from CONV-R and GF mice were
dissected out and immediately frozen in liquid nitrogen. Total RNA
was extracted from frozen liver tissue samples using RNeasy Mini
Kit (Qiagen, Hilden, Germany). About 0.5 lg of RNA was used for
cDNA synthesis, using High Capacity cDNA reverse transcription kit
(Applied Biosciences). Primers were obtained from Sigma, and
specificity was verified by Blast and the appearance of a single
product band of predicted size. qRT–PCR was performed in a CFX96
Real-time System (Bio-Rad). Expression levels of Nnt and Entpd4
were calculated relative to the mRNA expression of L32 and calcu-
lated with the DD-Ct method.
Reconstruction of mouse tissue-specific GEMs
SILAC-based proteome reflected the proteins expressed in the
specified tissues, and in total, 7,349 proteins were analyzed in 28
different major C57BL/6 mouse tissues. We reconstructed tissue-
specific GEMs for each tissue using the proteomics data (Geiger
et al, 2013) and recently developed tINIT algorithm (Agren et al,
2014). During the reconstruction of the 28 draft GEMs, we used 56
common tasks that are known to occur in all human cells (Agren
et al, 2014). These metabolic functions include the provision of
energy and redox, utilization, and internal conversion substrates as
well as the biosynthesis of certain metabolites. We compared these
automated tissue-specific GEMs and found that GEM for liver
contained the largest number of tissue-specific reactions,
metabolites, and genes, which represents its unique role in overall
host metabolism. Moreover, we reconstructed functional GEMs for
liver and adipose tissue using the previously developed human
models (Mardinoglu et al, 2013a, 2014a,b) and functional GEMs for
small intestine and colon tissues. It should be noted that we recon-
structed a functional generic GEM for small intestine rather than
specific GEMs for duodenum, jejunum, and ileum.
AA and N-acetylated AA level in CONV-R and GF mice
In order to validate our model-based predictions, we raised six
CONV-R and six GF C57Bl6/J mice and fed with autoclaved chow
diet. We collected blood samples from hepatic portal vein after
12 weeks and detected the level of the AAs and acteyl-AAs. Samples
were prepared using the automated MicroLab STAR system from
Hamilton Company. A recovery standard was added prior to the first
step in the extraction process for QC purposes. To remove protein,
dissociate small molecules bound to protein or trapped in the precip-
itated protein matrix, and to recover chemically diverse metabolites,
proteins were precipitated with methanol under vigorous shaking
for 2 min (Glen Mills GenoGrinder 2000) followed by centrifugation.
The liquid chromatography-tandem mass spectrometry (LC-MS/
MS) portion of the platform was based on a Waters ACQUITY ultra-
performance liquid chromatography (UPLC) and a Thermo-Finnigan
LTQ mass spectrometer operated at nominal mass resolution, which
consisted of an electrospray ionization (ESI) source and linear ion-
trap (LIT) mass analyzer. The sample extract was dried and then
reconstituted in acidic or basic LC-compatible solvents, each of
which contained 12 or more injection standards at fixed concentra-
tions. One aliquot was analyzed using acidic positive ion-optimized
conditions and the other using basic negative ion-optimized condi-
tions in two independent injections using separate dedicated
columns (Waters UPLC BEH C18-2.1 × 100 mm, 1.7 lm). Extracts
reconstituted in acidic conditions were gradient eluted using water
and methanol containing 0.1% formic acid, while the basic extracts,
which also used water/methanol, contained 6.5 mM ammonium
bicarbonate. The MS analysis alternated between MS and data-
dependent MS/MS scans using dynamic exclusion, and the scan
range was from 80 to 1,000 m/z.
Following log transformation and imputation of missing values,
if any, with the minimum observed value for each compound,
Welch’s two-sample t-test was used to identify AAs and
N-acetylated AAs that differed significantly between CONV-R and
GF mice, determined independently for each dataset. A summary of
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the numbers of biochemicals that achieved statistical significance
(P ≤ 0.05) is shown in Figs 3D and 4A and C. An estimate of the
false discovery rate (Q-value) is calculated to take into account the
multiple comparisons that normally occur in metabolomics-based
studies.
Integration of gene expression data into GEM for small intestine
using RMetD
In order to integrate gene expression data into GEMs, we developed
relative metabolic differences (RMetD), which allow for the applica-
tion of relative gene expressions between CONV-R and GF mice
rather than the absolute values, and simulated the metabolic
differences using the content of the diet (Dataset EV10). First, we
set the lower bounds of production of HDL and chylomicrons to
20% (arbitrary value) of their maximum production in GF small
intestine model. We performed flux variability analysis for all reac-
tions associated with the significantly (Q-value < 0.05) differentially
expressed genes in the model, and found the upper and lower
bound of these reactions. A reaction could be associated with more
than one gene, and these genes may have different expression
trends (e.g. one gene is up-regulated, whereas the other genes are
down-regulated). In such cases, we assumed that genes associated
with these reactions are not significantly changed (Q-value < 0.05).
Next, for reactions associated with the up-regulated genes in
CONV-R mice, we set both the upper and lower bounds of the reac-
tions in CONV-R model 20% (arbitrary value) more than the bound
of the reactions in GF model whereas 20% less for the reactions
associated with the down-regulated genes. By this way, reactions
with up-/down-regulated gene expression were able to carry more/
less fluxes. By adding these new constraints for each reaction in
CONV-R and GF mice together with the use of the content of the
diet, we predicted the fluxes of both models by maximizing the
production of chylomicrons and minimizing the sum of fluxes. For
all arbitrary values, we performed sensitivity analysis by using
different values and obtained similar results.
All the simulations were carried out using RAVEN toolbox
(Agren et al, 2013). RMetD source code was implemented in
MATLAB and RAVEN toolbox, and it is publically available at
https://sourceforge.net/projects/relative-metabolic-differences/files/
MiceStudy/.
Data availability
MMR generic mouse GEM, and functional GEMs for liver, adipose,
colon, and small intestine as well as the other mouse tissue GEMs
are publically available in the Systems Biology Mark-up Language
(SBML) format at Human Metabolic Atlas (http://www.metabolicat-
las.org) and at BioModels database with accession numbers
MODEL1509220000–MODEL1509220032. They are also provided as
Computer Code EV1.
Gene expression data from liver as well as epididymal and
subcutaneous WATs of CONV-R and GF mice are publically avail-
able in Gene Expression Omnibus (GEO) database with the acces-
sion number GSE31115.
Expanded View for this article is available online:
http://msb.embopress.org
Acknowledgements
This project was supported by the Bill & Melinda Gates Foundation, Knut
and Alice Wallenberg Foundation, Torsten Söderbergs Stiftelse, and
European Commission FP7 project METACARDIS with the grant agreement
HEALTH-F4-2012-305312, Novo Nordisk A/S, and Novo Nordisk Foundation.
We would like to thank Prof. Jan Borén, University of Gothenburg, for
providing constructive comments and Doruk Demircioglu for scientific
illustrations.
Author contributions
AM created MMR, generated tissue-specific models, and performed the analy-
sis of the gene expression data together with JN. SS performed the in silico
simulations between the bacteria. MB, EL, and FB generated gene expression
data for liver and adipose tissues, performed the PCR analysis, and measured
the level of amino acids and N-acetylated amino acids. PG compared the
tissue-specific models. CZ developed RMetD and performed the simulations of
the small intestine. AM and JN conceived the project.
Conflict of interest
The authors declare that they have no conflict of interest.
References
Agren R, Bordel S, Mardinoglu A, Pornputtapong N, Nookaew I, Nielsen J
(2012) Reconstruction of genome-scale active metabolic networks for 69
human cell types and 16 cancer types using INIT. PLoS Comput Biol 8:
e1002518
Agren R, Liu L, Shoaie S, Vongsangnak W, Nookaew I, Nielsen J (2013)
The RAVEN toolbox and its use for generating a genome-scale metabolic
model for Penicillium chrysogenum. PLoS Comput Biol 9: e1002980
Agren R, Mardinoglu A, Asplund A, Kampf C, Uhlen M, Nielsen J (2014)
Identification of anticancer drugs for hepatocellular carcinoma through
personalized genome-scale metabolic modeling. Mol Syst Biol 10: 721
Bordbar A, Monk JM, King ZA, Palsson BO (2014) Constraint-based models
predict metabolic and associated cellular functions. Nat Rev Genet 15:
107 – 120
Bordel S, Agren R, Nielsen J (2010) Sampling the solution space in genome-
scale metabolic networks reveals transcriptional regulation in key
enzymes. PLoS Comput Biol 6: e1000859
Claus SP, Tsang TM, Wang Y, Cloarec O, Skordi E, Martin FP, Rezzi S, Ross A,
Kochhar S, Holmes E, Nicholson JK (2008) Systemic multicompartmental
effects of the gut microbiome on mouse metabolic phenotypes. Mol Syst
Biol 4: 219
Duca FA, Swartz TD, Sakar Y, Covasa M (2012) Increased oral detection, but
decreased intestinal signaling for fats in mice lacking gut microbiota. PLoS
ONE 7: e39748
El Aidy S, Derrien M, Merrifield CA, Levenez F, Dore J, Boekschoten MV, Dekker
J, Holmes E, Zoetendal EG, van Baarlen P, Claus SP, Kleerebezem M (2013)
Gut bacteria-host metabolic interplay during conventionalisation of the
mouse germfree colon. ISME J 7: 743 – 755
Freeman HC, Hugill A, Dear NT, Ashcroft FM, Cox RD (2006) Deletion of
nicotinamide nucleotide transhydrogenase: a new quantitive trait locus
accounting for glucose intolerance in C57BL/6J mice. Diabetes 55:
2153 – 2156
Geiger T, Velic A, Macek B, Lundberg E, Kampf C, Nagaraj N, Uhlen M, Cox J,
Mann M (2013) Initial quantitative proteomic map of 28 mouse tissues
using the SILAC mouse. Mol Cell Proteomics 12: 1709 – 1722
ª 2015 The Authors Molecular Systems Biology 11: 834 | 2015
Adil Mardinoglu et al The effect of gut microbiota on host metabolism Molecular Systems Biology
13
Published online: October 16, 2015 
Ghaffari P, Mardinoglu A, Asplund A, Shoaie S, Kampf C, Uhlen M, Nielsen J
(2015) Identifying anti-growth factors for human cancer cell lines through
genome-scale metabolic modeling. Sci Rep 5: 8183
Gibson GR, Roberfroid MB (1995) Dietary modulation of the human colonic
microbiota: introducing the concept of prebiotics. J Nutr 125: 1401 – 1412
Gille C, Bolling C, Hoppe A, Bulik S, Hoffmann S, Hubner K, Karlstadt A,
Ganeshan R, Konig M, Rother K, Weidlich M, Behre J, Holzhutter HG
(2010) HepatoNet1: a comprehensive metabolic reconstruction of the
human hepatocyte for the analysis of liver physiology. Mol Syst Biol 6:
411
Henao-Mejia J, Elinav E, Jin C, Hao L, Mehal WZ, Strowig T, Thaiss CA, Kau AL,
Eisenbarth SC, Jurczak MJ, Camporez JP, Shulman GI, Gordon JI, Hoffman
HM, Flavell RA (2012) Inflammasome-mediated dysbiosis regulates
progression of NAFLD and obesity. Nature 482: 179 – 185
Huttenhower C, Gevers D, Knight R, Abubucker S, Badger JH, Chinwalla AT,
Creasy HH, Earl AM, FitzGerald MG, Fulton RS, Giglio MG,
Hallsworth-Pepin K, Lobos EA, Madupu R, Magrini V, Martin JC, Mitreva
M, Muzny DM, Sodergren EJ, Versalovic J et al (2012) Structure,
function and diversity of the healthy human microbiome. Nature 486:
207 – 214
Jerby L, Shlomi T, Ruppin E (2010) Computational reconstruction of tissue-
specific metabolic models: application to human liver metabolism. Mol
Syst Biol 6: 401
Kalhan SC, Guo LN, Edmison J, Dasarathy S, McCullough AJ, Hanson RW,
Milburn M (2011) Plasma metabolomic profile in nonalcoholic fatty liver
disease. Metabolism 60: 404 – 413
Kampf C, Mardinoglu A, Fagerberg L, Hallström B, Edlund K, Nielsen J, Uhlen
M (2014a) The human liver-specific proteome defined by transcriptomics
and antibody-based profiling. FASEB J 28: 2901 – 2914
Kampf C, Mardinoglu A, Fagerberg L, Hallstrom BM, Danielsson A, Nielsen J,
Ponten F, Uhlen M (2014b) Defining the human gallbladder proteome by
transcriptomics and affinity proteomics. Proteomics 14: 2498 – 2507
Karlsson FH, Fak F, Nookaew I, Tremaroli V, Fagerberg B, Petranovic D,
Backhed F, Nielsen J (2012) Symptomatic atherosclerosis is associated
with an altered gut metagenome. Nat Commun 3: 1245
Karlsson FH, Tremaroli V, Nookaew I, Bergstrom G, Behre CJ, Fagerberg B,
Nielsen J, Backhed F (2013) Gut metagenome in European women with
normal, impaired and diabetic glucose control. Nature 498: 99 – 103
Karlstaedt A, Fliegner D, Kararigas G, Ruderisch HS, Regitz-Zagrosek V,
Holzhutter HG (2012) CardioNet: a human metabolic network suited for
the study of cardiomyocyte metabolism. BMC Syst Biol 6: 114
Larsson E, Tremaroli V, Lee YS, Koren O, Nookaew I, Fricker A, Nielsen J, Ley
RE, Backhed F (2012) Analysis of gut microbial regulation of host gene
expression along the length of the gut and regulation of gut microbial
ecology through MyD88. Gut 61: 1124 – 1131
Ley RE, Turnbaugh PJ, Klein S, Gordon JI (2006) Microbial ecology: human gut
microbes associated with obesity. Nature 444: 1022 – 1023
Machado D, Herrgard M (2014) Systematic evaluation of methods for
integration of transcriptomic data into constraint-based models of
metabolism. PLoS Comput Biol 10: e1003580
Mardinoglu A, Agren R, Kampf C, Asplund A, Nookaew I, Jacobson P, Walley
AJ, Froguel P, Carlsson LM, Uhlen M, Nielsen J (2013a) Integration of
clinical data with a genome-scale metabolic model of the human
adipocyte. Mol Syst Biol 9: 649
Mardinoglu A, Gatto F, Nielsen J (2013b) Genome-scale modeling of human
metabolism - a systems biology approach. Biotechnol J 8: 985 – 996
Mardinoglu A, Agren R, Kampf C, Asplund A, Uhlen M, Nielsen J (2014a)
Genome-scale metabolic modelling of hepatocytes reveals serine
deficiency in patients with non-alcoholic fatty liver disease. Nat Commun
5: 3083
Mardinoglu A, Kampf C, Asplund A, Fagerberg L, Hallstrom BM, Edlund K,
Bluher M, Ponten F, Uhlen M, Nielsen J (2014b) Defining the human
adipose tissue proteome to reveal metabolic alterations in obesity. J
Proteome Res 13: 5106 – 5119
Mardinoglu A, Heiker JT, Gärtner D, Björnson E, Schön MR, Flehmig G, Klöting
N, Krohn K, Fasshauer M, Stumvoll M, Nielsen J, Blüher M (2015) Extensive
weight loss reveals distinct gene expression changes in human
subcutaneous and visceral adipose tissue. Sci Rep 5: 14841
Mardinoglu A, Nielsen J (2012) Systems medicine and metabolic modelling. J
Intern Med 271: 142 – 154
Mardinoglu A, Nielsen J (2015) New paradigms for metabolic modeling of
human cells. Curr Opin Biotech 34: 91 – 97
Newgard CB, An J, Bain JR, Muehlbauer MJ, Stevens RD, Lien LF, Haqq AM,
Shah SH, Arlotto M, Slentz CA, Rochon J, Gallup D, Ilkayeva O, Wenner BR,
Yancy WS, Eisenson H, Musante G, Surwit R, Millington DS, Butler MD
et al (2009) A branched-chain amino acid-related metabolic signature
that differentiates obese and lean humans and contributes to insulin
resistance (vol 9, pg 311, 2009). Cell Metab 9: 565 – 566
O’Brien EJ, Monk JM, Palsson BO (2015) Using genome-scale models to
predict biological capabilities. Cell 161: 971 – 987
Patil KR, Nielsen J (2005) Uncovering transcriptional regulation of metabolism
by using metabolic network topology. Proc Natl Acad Sci USA 102:
2685 – 2689
Pornputtapong N, Nookaew I, Nielsen J (2015) Human metabolic atlas: an
online resource for human metabolism. Database 2015: bav068
Qin JJ, Li YR, Cai ZM, Li SH, Zhu JF, Zhang F, Liang SS, Zhang WW, Guan YL,
Shen DQ, Peng YQ, Zhang DY, Jie ZY, Wu WX, Qin YW, Xue WB, Li JH, Han
LC, Lu DH, Wu PX et al (2012) A metagenome-wide association study of
gut microbiota in type 2 diabetes. Nature 490: 55 – 60
Rabot S, Membrez M, Bruneau A, Gerard P, Harach T, Moser M, Raymond F,
Mansourian R, Chou CJ (2010) Germ-free C57BL/6J mice are resistant to
high-fat-diet-induced insulin resistance and have altered cholesterol
metabolism. FASEB J 24: 4948 – 4959
Ridaura VK, Faith JJ, Rey FE, Cheng J, Duncan AE, Kau AL, Griffin NW,
Lombard V, Henrissat B, Bain JR, Muehlbauer MJ, Ilkayeva O, Semenkovich
CF, Funai K, Hayashi DK, Lyle BJ, Martini MC, Ursell LK, Clemente JC, Van
Treuren W et al (2013) Gut microbiota from twins discordant for obesity
modulate metabolism in mice. Science 341: 1241214
Ripoll VM, Meadows NA, Bangert M, Lee AW, Kadioglu A, Cox RD (2012)
Nicotinamide nucleotide transhydrogenase (NNT) acts as a novel
modulator of macrophage inflammatory responses. FASEB J 26: 3550 – 3562
Sayin SI, Wahlstrom A, Felin J, Jantti S, Marschall HU, Bamberg K, Angelin B,
Hyotylainen T, Oresic M, Backhed F (2013) Gut microbiota regulates bile
acid metabolism by reducing the levels of tauro-beta-muricholic acid, a
naturally occurring FXR antagonist. Cell Metab 17: 225 – 235
Shoaie S, Karlsson F, Mardinoglu A, Nookaew I, Bordel S, Nielsen J (2013)
Understanding the interactions between bacteria in the human gut
through metabolic modeling. Sci Rep 3: 2532
Shoaie S, Nielsen J (2014) Elucidating the interactions between the human
gut microbiota and its host through metabolic modeling. Front Genet 5:
86
Shoaie S, Ghaffari P, Kovatcheva-Datchary P, Mardinoglu A, Sen P, Pujos-
Guillot E, de Wouters T, Juste C, Rizkalla S, Chilloux J, Hoyles L, Nicholson
JK, Consortium M-O, Dore J, Dumas ME, Clement K, Bäckhed F, Nielsen J
(2015) Quantifying diet-induced metabolic changes of the human gut
microbiome. Cell Metab 22: 320 – 331
Molecular Systems Biology 11: 834 | 2015 ª 2015 The Authors
Molecular Systems Biology The effect of gut microbiota on host metabolism Adil Mardinoglu et al
14
Published online: October 16, 2015 
Slack E, Hapfelmeier S, Stecher B, Velykoredko Y, Stoel M, Lawson MAE,
Geuking MB, Beutler B, Tedder TF, Hardt WD, Bercik P, Verdu EF, McCoy
KD, Macpherson AJ (2009) Innate and adaptive immunity cooperate
flexibly to maintain host-microbiota mutualism. Science 325: 617 – 620
Smith MI, Yatsunenko T, Manary MJ, Trehan I, Mkakosya R, Cheng J, Kau AL,
Rich SS, Concannon P, Mychaleckyj JC, Liu J, Houpt E, Li JV, Holmes E,
Nicholson J, Knights D, Ursell LK, Knight R, Gordon JI (2013) Gut
microbiomes of Malawian twin pairs discordant for kwashiorkor. Science
339: 548 – 554
Sommer F, Nookaew I, Sommer N, Fogelstrand P, Backhed F (2015) Site-
specific programming of the host epithelial transcriptome by the gut
microbiota. Genome Biol 16: 62
Stappenbeck TS, Hooper LV, Gordon JI (2002) Developmental regulation of
intestinal angiogenesis by indigenous microbes via Paneth cells. Proc Natl
Acad Sci USA 99: 15451 – 15455
Subramanian S, Huq S, Yatsunenko T, Haque R, Mahfuz M, Alam MA, Benezra
A, DeStefano J, Meier MF, Muegge BD, Barratt MJ, VanArendonk LG, Zhang
Q, Province MA, Petri WA Jr, Ahmed T, Gordon JI (2014) Persistent gut
microbiota immaturity in malnourished Bangladeshi children. Nature 510:
417 – 421
Turnbaugh PJ, Hamady M, Yatsunenko T, Cantarel BL, Duncan A, Ley RE,
Sogin ML, Jones WJ, Roe BA, Affourtit JP, Egholm M, Henrissat B, Heath AC,
Knight R, Gordon JI (2009) A core gut microbiome in obese and lean
twins. Nature 457: 480 – 484
Uhlen M, Oksvold P, Fagerberg L, Lundberg E, Jonasson K, Forsberg M,
Zwahlen M, Kampf C, Wester K, Hober S, Wernerus H, Bjorling L, Ponten F
(2010) Towards a knowledge-based Human Protein Atlas. Nat Biotechnol
28: 1248 – 1250
Uhlen M, Fagerberg L, Hallstrom BM, Lindskog C, Oksvold P, Mardinoglu A,
Sivertsson A, Kampf C, Sjöstedt E, Asplund A, Lundberg E, Djureinovic D,
Odeberg J, Habuka M, Tahmasebpoor S, Danielsson A, Edlund K, Szigyarto
CA, Skogs M, Takanen JO et al (2015) Tissue-based map of the human
proteome. Science 347: 1260419
Van den Abbeele P, Belzer C, Goossens M, Kleerebezem M, De Vos WM, Thas
O, De Weirdt R, Kerckhof FM, Van de Wiele T (2013) Butyrate-producing
Clostridium cluster XIVa species specifically colonize mucins in an in vitro
gut model. ISME J 7: 949 – 961
Väremo L, Nielsen J, Nookaew I (2013) Enriching the gene set analysis of
genome-wide data by incorporating directionality of gene expression and
combining statistical hypotheses and methods. Nucleic Acids Res 4:
4378 – 4391
Varemo L, Scheele C, Broholm C, Mardinoglu A, Kampf C, Asplund A, Nookaew
I, Uhlen M, Pedersen BK, Nielsen J (2015) Proteome- and transcriptome-
driven reconstruction of the human myocyte metabolic network and its
use for identification of markers for diabetes. Cell Rep 11: 921 – 933
Velagapudi VR, Hezaveh R, Reigstad CS, Gopalacharyulu P, Yetukuri L, Islam S,
Felin J, Perkins R, Boren J, Oresic M, Backhed F (2010) The gut microbiota
modulates host energy and lipid metabolism in mice. J Lipid Res 51:
1101 – 1112
Wang TJ, Larson MG, Vasan RS, Cheng S, Rhee EP, McCabe E, Lewis GD, Fox
CS, Jacques PF, Fernandez C, O’Donnell CJ, Carr SA, Mootha VK, Florez JC,
Souza A, Melander O, Clish CB, Gerszten RE (2011a) Metabolite profiles
and the risk of developing diabetes. Nat Med 17: 448 – 453
Wang Z, Klipfell E, Bennett BJ, Koeth R, Levison BS, Dugar B, Feldstein AE,
Britt EB, Fu X, Chung YM, Wu Y, Schauer P, Smith JD, Allayee H, Tang WH,
DiDonato JA, Lusis AJ, Hazen SL (2011b) Gut flora metabolism of
phosphatidylcholine promotes cardiovascular disease. Nature 472: 57 – 63
Wang YL, Eddy JA, Price ND (2012) Reconstruction of genome-scale metabolic
models for 126 human tissues using mCADRE. BMC Syst Biol 6: 153
Whitt DD, Demoss RD (1975) Effect of microflora on the free amino acid
distribution in various regions of the mouse gastrointestinal tract. Appl
Microbiol 30: 609 – 615
Wostmann BS (1981) The germfree animal in nutritional studies. Annu Rev
Nutr 1: 257 – 279
Yin F, Sancheti H, Cadenas E (2012) Silencing of nicotinamide nucleotide
transhydrogenase impairs cellular redox homeostasis and energy
metabolism in PC12 cells. Biochim Biophys Acta 1817: 401 – 409
Yizhak K, Gabay O, Cohen H, Ruppin E (2013) Model-based identification of
drug targets that revert disrupted metabolism and its application to
ageing. Nat Commun 4: 2632
Yizhak K, Gaude E, Le Devedec S, Waldman YY, Stein GY, van de Water B,
Frezza C, Ruppin E (2014a) Phenotype-based cell-specific metabolic
modeling reveals metabolic liabilities of cancer. Elife 3: e03641
Yizhak K, Le Devedec SE, Rogkoti VM, Baenke F, de Boer VC, Frezza C, Schulze
A, van de Water B, Ruppin E (2014b) A computational study of the
Warburg effect identifies metabolic targets inhibiting cancer migration.
Mol Syst Biol 10: 744
Zhang C, Ji B, Mardinoglu A, Nielsen J, Hua Q (2015) Logical transformation of
genome-scale metabolic models for gene level applications and analysis.
Bioinformatics 31: 2324 – 2331
Zoetendal EG, Raes J, van den Bogert B, Arumugam M, Booijink CCGM, Troost
FJ, Bork P, Wels M, de Vos WM, Kleerebezem M (2012) The human small
intestinal microbiota is driven by rapid uptake and conversion of simple
carbohydrates. ISME J 6: 1415 – 1426
License: This is an open access article under the
terms of the Creative Commons Attribution 4.0
License, which permits use, distribution and reproduc-
tion in any medium, provided the original work is
properly cited.
ª 2015 The Authors Molecular Systems Biology 11: 834 | 2015
Adil Mardinoglu et al The effect of gut microbiota on host metabolism Molecular Systems Biology
15
Published online: October 16, 2015 
